Show simple item record

Force Characteristics of In Vivo Tissue-engineered Myocardial Constructs Using Varying Cell Seeding Densities

dc.contributor.authorBirla, Ravi K.en_US
dc.contributor.authorDhawan, Vikasen_US
dc.contributor.authorHuang, Yen-Chihen_US
dc.contributor.authorLytle, Ian F.en_US
dc.contributor.authorTiranathanagul, Khajohnen_US
dc.contributor.authorBrown, Daviden_US
dc.date.accessioned2010-06-01T19:24:03Z
dc.date.available2010-06-01T19:24:03Z
dc.date.issued2008-09en_US
dc.identifier.citationBirla, Ravi; Dhawan, Vikas; Huang, Yen-Chih; Lytle, Ian; Tiranathanagul, Khajohn; Brown, David (2008). "Force Characteristics of In Vivo Tissue-engineered Myocardial Constructs Using Varying Cell Seeding Densities." Artificial Organs 32(9): 684-691. <http://hdl.handle.net/2027.42/72542>en_US
dc.identifier.issn0160-564Xen_US
dc.identifier.issn1525-1594en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72542
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18684210&dopt=citationen_US
dc.description.abstractExperiments have been successfully performed culminating in functional, vascularized, three-dimensional cardiac muscle tissue. Past experience in tissue engineering has led us to the understanding that cell seeding density plays a critical role in the formation and function of both in vitro and in vivo engineered tissues. Therefore, to improve upon the mechanics of this model and to facilitate the formation of myocardial tissue with improved functional performance, we sought to optimize the seeding density of cardiomyocytes in these constructs. Neonatal cardiac myocytes were isolated from 2-day-old Fischer 344 rat hearts. Silicone chambers containing fibrin gel were seeded with varying numbers of cardiac cells (1, 5, 10, and 20 million). Control chambers were prepared using fibrin gel alone. All of the chambers were then implanted around the femoral vessels of isogenic rats. Six constructs per cell seeding density group were implanted. Histological and immunohistochemical evaluation was performed via hematoxylin and eosin, von Gieson, and α-sarcomeric actin staining protocols. Linear contractile force measurements were obtained for each construct following 4 weeks of in vivo implantation. After an implantation period of 4 weeks, the newly formed cardiac constructs contained within the chambers were harvested. The femoral vessels within the constructs were found to be patent in all cases. With direct electrical stimulation, the constructs were able to generate an average active force that varied depending on their seeding density. Constructs with seeding densities of 1, 5, 10, and 20 million cells produced an average active force of 208, 241, 151, and 108 µN, respectively. The control constructs did not generate any active force on electrical stimulation. This study demonstrates the in vivo survival, vascularization, organization, and function of transplanted myocardial cells. It is also apparent that cell seeding density plays a direct role in the force generation and mechanical properties of these engineered constructs. Among different groups using varying cell seeding densities, we found that the group with 5 million cells generated maximum active force.en_US
dc.format.extent377287 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Incen_US
dc.rightsJournal compilation © 2008 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.en_US
dc.subject.otherCardiac Myocytesen_US
dc.subject.otherActive Forceen_US
dc.subject.otherCell Seeding Densityen_US
dc.subject.otherImplantationen_US
dc.subject.otherAngiogenesisen_US
dc.subject.otherTissue Engineeringen_US
dc.titleForce Characteristics of In Vivo Tissue-engineered Myocardial Constructs Using Varying Cell Seeding Densitiesen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationum† Section of Internal Medicine, University of Michigan, Ann Arbor, MI, USAen_US
dc.contributor.affiliationother* Section of Cardiac Surgery,en_US
dc.contributor.affiliationother† Section of Plastic Surgery, anden_US
dc.identifier.pmid18684210en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72542/1/j.1525-1594.2008.00591.x.pdf
dc.identifier.doi10.1111/j.1525-1594.2008.00591.xen_US
dc.identifier.sourceArtificial Organsen_US
dc.identifier.citedreferenceShimizu T, Yamato M, Kikuchi A, Okano T. Two-dimensional manipulation of cardiac myocyte sheets utilizing temperature-responsive culture dishes augments the pulsatile amplitude. Tissue Eng 2001; 7: 141 – 51.en_US
dc.identifier.citedreferenceShimizu T, Yamato M, Akutsu T, et al. Electrically communicating three-dimensional cardiac tissue mimic fabricated by layered cultured cardiomyocyte sheets. J Biomed Mater Res 2002; 60: 110 – 7.en_US
dc.identifier.citedreferenceShimizu T, Yamato M, Isoi Y, et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 2002; 90: e40.en_US
dc.identifier.citedreferenceShimizu T, Yamato M, Kikuchi A, Okano T. Cell sheet engineering for myocardial tissue reconstruction. [Review][38 refs]. Biomaterials 2003; 24: 2309 – 16.en_US
dc.identifier.citedreferenceBursac N, Papadaki M, Cohen RJ, et al. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am J Physiol 1999; 277: t - 44.en_US
dc.identifier.citedreferenceCarrier RL, Papadaki M, Rupnick M, et al. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng 1999; 64: 580 – 9.en_US
dc.identifier.citedreferencePapadaki M, Bursac N, Langer R, Merok J, Vunjak-Novakovic G, Freed LE. Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am J Physiol Heart Circ Physiol 2001; 280: H168 – 78.en_US
dc.identifier.citedreferencePapadaki M. Cardiac muscle tissue engineering. [Review][13 refs]. IEEE Eng Med Biol 2003; 22: 153 – 4.en_US
dc.identifier.citedreferenceRadisic M, Euloth M, Yang L, Langer R, Freed LE, Vunjak-Novakovic G. High-density seeding of myocyte cells for cardiac tissue engineering. Biotechnol Bioeng 2003; 82: 403 – 14.en_US
dc.identifier.citedreferenceEschenhagen T, Fink C, Remmers U, et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J 1997; 11: 683 – 94.en_US
dc.identifier.citedreferenceEschenhagen T, Didie M, Munzel F, Schubert P, Schneiderbanger K, Zimmermann WH. 3D engineered heart tissue for replacement therapy. Basic Res Cardiol 2002; 97: Suppl 1: I146 – 52.en_US
dc.identifier.citedreferenceZimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 2000; 68: 106 – 14.en_US
dc.identifier.citedreferenceZimmermann WH, Schneiderbanger K, Schubert P, et al. Tissue engineering of a differentiated cardiac muscle construct. [See comments.] Circ Res 2002; 90: 223 – 30.en_US
dc.identifier.citedreferenceZimmermann WH, Eschenhagen T. Cardiac tissue engineering for replacement therapy. [Review][79 refs]. Heart Fail Rev 2003; 8: 259 – 69.en_US
dc.identifier.citedreferenceMauck RL, Wang CC, Oswald ES, Ateshian GA, Hung CT. The role of cell seeding density and nutrient supply for articular cartilage tissue engineering with deformational loading. Osteoarthritis Cartilage 2003; 11: 879 – 90.en_US
dc.identifier.citedreferenceKim EJ, Li RK, Weisel RD, et al. Angiogenesis by endothelial cell transplantation. [See comment.] J Thorac Cardiovasc Surg 2001; 122: 963 – 71en_US
dc.identifier.citedreferenceDar A, Shachar M, Leor J, Cohen S. Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnol Bioeng 2002; 80: 305 – 12.en_US
dc.identifier.citedreferenceHuang YC, Khait L, Birla RK. Contractile three-dimensional bioengineered heart muscle for myocardial regeneration. J Biomed Mater Res 2007; 80: 719 – 31.en_US
dc.identifier.citedreferenceBirla RK, Borschel GH, Dennis RG, Brown DL. Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Eng 2005; 11: 803 – 13.en_US
dc.identifier.citedreferenceDennis RG, Kosnik PE. Excitability and isometric contractile properties of mammalian skeletal muscle constructs engineered in vitro. In Vitro Cell Dev Biol Anim 2000; 36: 327 – 35.en_US
dc.identifier.citedreferenceKosnik PE, Faulkner JA, Dennis RG. Functional development of engineered skeletal muscle from adult and neonatal rats. Tissue Eng 2001; 7: 573 – 84.en_US
dc.identifier.citedreferenceMenaschÉ P, HagÈge AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41: 1078 – 83.en_US
dc.identifier.citedreferenceElmadbouh I, Chen Y, Louedec L, et al. Mesothelial cell transplantation in the infarct scar induces neovascularization and improves heart function. Cardiovasc Res 2005; 68: 307 – 17.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.